Hetero Biopharma Limited

Pharmaceutical company manufacturing various medical products, established in 2016 and based in Hyderabad.

2016 | Rangareddy, Telangana (India) | Active
Last Updated:

Hetero Biopharma Profile

Key Indicators

  • Authorised Capital ₹ 166.00 Cr
  • Paid Up Capital ₹ 30.05 Cr
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 94.15 Cr
  • Revenue Growth 13.44%
  • Profit Growth -33.65%
  • Ebitda -6.70%
  • Net Worth 22.99%
  • Total Assets 26.05%

About Hetero Biopharma

Hetero Biopharma Limited (HBL) is a Public Limited Indian Non-Government Company incorporated in India on 14 September 2016 (Eight years and five months 19 days old ). Its registered office is in Rangareddy, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 166.00 Cr and a paid-up capital of Rs 30.05 Cr.

The company currently has active open charges totaling ₹94.15 Cr.

The Key Managerial Personnel (KMP) at Hetero Biopharma Limited India are Divyanshu Patidar as CFO and Janardhan Katersala as Company Secretary. Parthasaradhi Bandi, Bandi Vamsikrishna, Chandra Tumuluru, and Two other members serve as directors at the Company.

Company Details

  • Location

    Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    hetero.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24290TG2016PLC111946

  • Company No.

    111946

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    14 Sep 2016

  • Date of AGM

    19 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Hetero Biopharma?

Executive Team (2)

NameDesignationAppointment DateStatus
Divyanshu Patidar CFO30-Sep-2023Current
Janardhan Katersala Company Secretary29-Dec-2023Current

Board Members (5)

NameDesignationAppointment DateStatus
Parthasaradhi Bandi Country flag representing In Director 14-Sep-2016Current
Bandi Vamsikrishna Country flag representing In Director 25-Mar-2021Current
Chandra Tumuluru Country flag representing In Director 16-Jul-2021Current
Govindaraju Bhavani Country flag representing In Director 26-Aug-2022Current
Bhavesh Pujara Country flag representing In Director 14-Jun-2024Current

Financial Performance of Hetero Biopharma.

Hetero Biopharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.44% increase. The company also saw a substantial fall in profitability, with a 33.65% decrease in profit. The company's net worth Soared by an impressive increase of 22.99%.

Hetero Biopharma revenue growth over time
Hetero Biopharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
13.44%
Revenue from Operations
13.81%
Total Assets
26.05%
Profit or Loss
-33.65%
Net Worth
22.99%
EBITDA
-6.70%

What is the Ownership and Shareholding Structure of Hetero Biopharma?

In 2024, Hetero Biopharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹94.15 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 94.15 Cr

Latest Charge Details

DateLenderAmountStatus
14 Feb 2024Others₹2.50 MOpen
20 Feb 2023Others₹2.00 MOpen
07 Jun 2022Others₹9.79 MOpen
14 Sep 2021Others₹92.72 CrOpen

How Many Employees Work at Hetero Biopharma?

Hetero Biopharma has a workforce of 486 employees as of Feb 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Hetero Biopharma Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hetero Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Biopharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Hetero Biopharma

Recent activity within the organization

  • Charges

    A charge with Others of Rs. 92.72 Cr registered on 14 Sep 2021 with Charge ID 100482619 was modified on 17 Dec 2024.

  • Annual General Meeting

    Hetero Biopharma Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records.

  • Director Appointment

    Bhavesh Bansidhar Pujara was appointed as a Director was appointed as a Director on 14 Jun 2024 & has been associated with this company since 8 months 19 days .

  • Balance Sheet

    Hetero Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Charges

    A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100890394 was registered on 14 Feb 2024.

  • Director Appointment

    Janardhan Katersala was appointed as a Company Secretary was appointed as a Company Secretary on 29 Dec 2023 & has been associated with this company since 1 year 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Hetero Biopharma Limited?

    Hetero Biopharma Limited was incorporated on 14 Sep 2016.

  • What is authorized share capital and paid-up capital of Hetero Biopharma Limited?

    The authorized share capital of Hetero Biopharma Limited is ₹ 166.00 Cr and paid-up capital is ₹ 30.05 Cr.

  • Who are the current board members & directors of Hetero Biopharma Limited?

    Currently 7 directors are associated with Hetero Biopharma Limited.

    • Parthasaradhi Reddy Bandi
    • Bandi Vamsikrishna
    • Chandra Sekhar Tumuluru
    • Govindaraju Bhavani
    • Bhavesh Bansidhar Pujara
    • Divyanshu Patidar
    • Janardhan Katersala

  • What is the registered address of Hetero Biopharma Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Hetero Biopharma Limited is 7-2-A2 Industrial Estate Sanath Nagar, India, Balanagar, Telangana, 500018.

  • What is the corporate identification number (CIN) and company number of Hetero Biopharma Limited?

    The corporate identification number (CIN) of Hetero Biopharma Limited is U24290TG2016PLC111946 and the company number is 111946 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Hetero Biopharma Limited?

    The Official website of Hetero Biopharma Limited is https://www.hetero.com

  • What has been the recent revenue trend for Hetero Biopharma Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Hetero Biopharma Limited has risen by 13.44%.

  • How many employees does Hetero Biopharma Limited currently have?

    As Per 2024 financial reports, 486 employees are currently employed by Hetero Biopharma Limited.

  • What change has been observed in the net worth of Hetero Biopharma Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Hetero Biopharma Limited has experienced an upsurge of 22.99%.

  • What are the total open charges for Hetero Biopharma Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Hetero Biopharma Limited amount to ₹ 94.15 Cr.

  • When was the last Balance Sheet of Hetero Biopharma Limited filed with the ROC?

    The most recent Balance Sheet for Hetero Biopharma Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development